Graf Akcie ELOX (Eloxx Pharmaceuticals Inc). Diskuze k akciím ELOX. Aktuální informace ELOX.

Základní informace o společnosti Eloxx Pharmaceuticals Inc (Akcie ELOX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 134.46M
Hodnota podniku (EV) N/A
Tržby 0.00
EBITDA N/A
Zisk -57.50
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 0.00
Forward P/E N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales N/A
P/FCF N/A
Price/Book 13.14
Účetní hodnota na akcii 0.12
Hotovost na akcii 0.29
FCF vůči ceně -20.38 %
Počet zaměstnanců 25
Tržba na zaměstnance 0.00
Profit margin N/A %
Operating margin N/A %
Gross margin N/A %
EBIT margin N/A %
EBITDA margin N/A %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 170.00 %
EPS - Očekávaný růst příští rok -18.75 %
Return on assets -163.81 %
Return on equity -334.76 %
ROIC -80.95 %
ROCE -126.64 %
Dluhy/Equity 1.59
Čistý dluh/EBITDA 2.14
Current ratio 3.85
Quick Ratio 3.85
Volatilita 6.10
Beta 0.54
RSI 45.33
Cílová cena analytiků 5
Známka akcie (dle analytiků) 1.67
Insider ownership 2.11 %
Institutional ownership 58.63 %
Počet akcií 86.203M
Procento shortovaných akcií 2.61 %
Short ratio 1.73 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1999
Země United States

Finanční výsledky akcie ELOX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue-----$0.075
Cost Of Goods Sold------
Gross Profit-----$0.075
Research And Development Expenses$25.842$20.489$16.398$0.734$8.986$2.183
SG&A Expenses$24.713$26.482$2.702$1.409$0.854$1.606
Other Operating Income Or Expenses-$-0.594$-1.29$-2.45-$-7.481
Operating Expenses$50.555$47.565$20.39$4.593$9.84$11.27
Operating Income$-50.555$-47.565$-20.39$-4.593$-9.84$-11.195
Total Non-Operating Income/Expense$-0.319$0.502$-0.824$-2.244$-0.007$2.247
Pre-Tax Income$-50.874$-47.063$-21.214$-6.836$-9.847$-8.948
Income Taxes-$0.122-$-1.04-$-0.68
Income After Taxes$-50.874$-47.185$-21.214$-5.796$-9.847$-8.268
Other Income------
Income From Continuous Operations$-50.874$-47.185$-21.214$-5.796$-9.847$-8.268
Income From Discontinued Operations------
Net Income$-50.874$-47.185$-23.618$-6.194$-10.947$-8.447
EBITDA$-49.762$-47.349$-19.683$-4.549$-9.832$-11.102
EBIT$-50.555$-47.565$-20.39$-4.593$-9.84$-11.195
Basic Shares Outstanding3832523420
Shares Outstanding3832523420
Basic EPS$-1.34$-1.45$-4.75$-0.27$-2.60$-0.42
EPS - Earnings Per Share$-1.34$-1.45$-4.75$-0.27$-2.60$-0.42
# 2020 2019 2018 2017 2016 2015
Current Ratio4.88776.44827.15920.1025-2.663
Long-term Debt / Capital0.2248-----
Debt/Equity Ratio0.4097--0.4673--
Gross Margin-----100
Operating Margin------14926.64
EBIT Margin------14926.64
EBITDA Margin------14802.12
Pre-Tax Profit Margin------11930.57
Net Profit Margin------11262.78
Asset Turnover-----0.0081
Inventory Turnover Ratio------
Receiveable Turnover------
Days Sales In Receivables------
ROE - Return On Equity-140.4855-109.9602-99.3118-666.5388--181.3817
Return On Tangible Equity-140.4855-109.9602-99.3118-665.3261--181.2881
ROA - Return On Assets-86.3047-93.034-85.5956-99.1645--89.616
ROI - Return On Investment-108.9029-109.9602-99.3118-665.3264--181.2881
Book Value Per Share0.90461.19660.7760.0298-0.2225
Operating Cash Flow Per Share-0.06792.2354-3.11952.0203-1.92230.3285
Free Cash Flow Per Share-0.06182.2759-3.1672.0288-1.93090.3371

Porovnání s konkurencí: Akcie ELOX

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
ELOX 0.00 N/A N/A % -18.75 % -334.76 % 13.14 N/A %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %

Nedávné obchody insiderů: Akcie ELOX

Jméno Obchod Cena Objem
Robert Ward
Option
29 Feb 2020
$3.13 $240,403
David P. Snow
Option
29 Feb 2020
$3.13 $14,673
Gregory L Weaver
Option
15 Mar 2020
$2.85 $10,688
Neil S. Belloff
COO, General Counsel, and CORP SEC
Option
30 Apr 2020
$2.92 $4,561
Gregory C. Williams
CHIEF EXECUTIVE OFFICER
Option
30 Apr 2020
$2.92 $5,475
Gregory C. Williams
CHIEF EXECUTIVE OFFICER
Option
30 Jul 2020
$2.84 $5,325
Neil S. Belloff
COO, General Counsel, and CORP SEC
Option
30 Jul 2020
$2.84 $4,439
Neil S. Belloff
COO, General Counsel, and CORP SEC
Option
30 Oct 2020
$2.53 $3,952
Gregory C. Williams
CHIEF EXECUTIVE OFFICER
Option
30 Oct 2020
$2.53 $4,744
Neil S. Belloff
COO, General Counsel, and CORP SEC
Option
30 Jan 2021
$3.44 $5,377
Gregory C. Williams
CHIEF EXECUTIVE OFFICER
Option
30 Jan 2021
$3.44 $6,450
Robert Ward
Option
29 Feb 2020
$3.13 $240,403
David P. Snow
Option
29 Feb 2020
$3.13 $14,673
Gregory L Weaver
Option
15 Mar 2020
$2.85 $10,688
Neil S. Belloff
COO, General Counsel, and CORP SEC
Option
30 Apr 2020
$2.92 $4,561
Gregory C. Williams
CHIEF EXECUTIVE OFFICER
Option
30 Apr 2020
$2.92 $5,475
Gregory C. Williams
CHIEF EXECUTIVE OFFICER
Option
30 Jul 2020
$2.84 $5,325
Neil S. Belloff
COO, General Counsel, and CORP SEC
Option
30 Jul 2020
$2.84 $4,439
Neil S. Belloff
COO, General Counsel, and CORP SEC
Option
30 Oct 2020
$2.53 $3,952
Gregory C. Williams
CHIEF EXECUTIVE OFFICER
Option
30 Oct 2020
$2.53 $4,744
Neil S. Belloff
COO, General Counsel, and CORP SEC
Option
30 Jan 2021
$3.44 $5,377
Gregory C. Williams
CHIEF EXECUTIVE OFFICER
Option
30 Jan 2021
$3.44 $6,450

Diskuze k akciím ELOX